Recall Register

Drug recall: Hydromorphone HCl in 0.9% sodium chloride, 0.5mg per mL, 1 mL in 3mL BD Syringe, PharMEDium 913 N Davis Ave Cleveland…

Class I FDA enforcement event 83207. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Incorrect Product Formulation; Firm's customer resource center (CRC) statement indicates that the product is sulfite free, however the product is produced with a raw material that contains sulfite

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

PharMEDium Services, LLC started this drug recall on 7 Jun 2019. The firm address in the FDA record is in Dayton, NJ. FDA put the recall in Class I. FDA event 83207 has 1 product record. The first FDA enforcement report date is 10 Jul 2019. The record gives the status Terminated, with the termination date 2 Jun 2020. 124 of the 362 drug events that started in 2019 have more product records. The median drug event of 2019 has 1 product record. The openFDA file has 362 drug events that started in 2019 and 367 that started in 2018.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide within the United States

Recalling firm

PharMEDium Services, LLC, Dayton, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 83207: product records
Recall numberProductQuantityClassStatusReport date
D-1488-2019Hydromorphone HCl in 0.9% sodium chloride, 0.5mg per mL, 1 mL in 3mL BD Syringe, PharMEDium 913 N Davis Ave Cleveland, MS 38732, 800-523-7749, NDC 61553-352-7828,140 syringesClass ITerminated10 Jul 2019

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2019
362
Share of these events in Class I
10%
Product records in this event
1Median of the firm: 2
Events of the firm on the register
30

Other events of the firm

Other FDA enforcement events of PharMEDium Services, LLC
InitiatedProduct (first record)TypeClassRecords
16 Mar 2020ePHEDrine Sulfate, 5 mg per mL, 50 mg per 10 mL, In 0.9% Sodium Chloride 10 mL syringe, For IV Use Preservative Free PhaDrugClass II13
16 Dec 2019NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00 mL Viaflex DrugClass III3
2 Jan 20190.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% BDrugClass II1
5 Dec 2018Fentanyl Citrate 2 mcg per mL (100 mcg per 50 mL) and Ropivacaine HCl 0.1% in Sodium Chloride 0.9%, Injection, 50 mL totDrugClass II2
24 Jul 201810 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 250 mL in 250 mL Intravia Bag and 10 mcg/mL FentaDrugClass II3
5 Jun 2018HYDROmorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride, 1 mL Total Volume in 3 mL syringe, Rx, PharMEDium Services, LLCDrugClass II1
10 Apr 2018Vasopressin 50 Units added to 250 mL 0.9% Sodium Chloride Injection USP (0.2 units per mL), Rx only, PharMEDium ServicesDrugClass III1
5 Feb 201815 units Oxytocin added to 0.9% Sodium Chloride Injection, 250 mL Viaflex Bag, Rx only, PharMEDium Serivces, LLCDrugClass II3
27 Dec 2017HYDROmorphone HCl in Sodium Chloride 0.9% in all doses, all strengths, and all packaging.DrugClass II42
30 Oct 2017ePHEDrine Sulfate In 0.9% Sodium Chloride, 5 mg per mL (50 mg per 10 mL), 10 mL Total Volume pre-filled syringes, packagDrugClass II1

PharMEDium Services, LLC: all 30 events

Official channels

Cite this page

Recall Register. FDA enforcement event 83207. https://recallregister.com/fda/i/83207/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide within the United States
What quantity of product is in FDA event 83207?
The FDA record gives this quantity: 28,140 syringes
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2019 have the same class?
10% of the 362 drug events that started in 2019 are in Class I.